First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
18 hedge funds and large institutions have $16M invested in First Trust Nasdaq Pharmaceuticals ETF in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.19M | |
| 2 | +$718K | |
| 3 | +$608K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$513K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$253K |
Top Sellers
| 1 | -$262K | |
| 2 | -$197K | |
| 3 | -$44.5K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$35.4K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$34K |